open access

Vol 1, No 1 (2016)
ORIGINAL PAPERS
Published online: 2016-03-30
Get Citation

Clinical outcomes of primary vitrectomy in pseudophakic retinal detachment

Katarzyna Nowomiejska, Agnieszka Kalinowska, Dominika Nowakowska, Agnieszka Brzozowska, Anselm G. Jünemann, Robert Rejdak
DOI: 10.5603/OJ.2016.0004
·
Ophthalmology J 2016;1(1):24-28.

open access

Vol 1, No 1 (2016)
ORIGINAL PAPERS
Published online: 2016-03-30

Abstract

PURPOSE. To evaluate the efficacy of primary pars plana vitrectomy (PPV) for rhematogenous retinal detachment (RD) in pseudophakic eyes.

MATERIALS AND METHODS. The medical records of 63 patients who had undergone PPV after phacoemulsification were reviewed retrospectively. The mean follow-up period was 10 months. Statistical analysis evaluated functional and anatomical results as well as general (diabetes, hypertension) and ocular (myopia, glaucoma, floppy iris syndrome, intraoperative complications during cataract surgery, YAG capsulotomy) conditions.

RESULTS. The median period from cataract surgery to RD onset was 15 months. Retinal attachment was achieved in 92% of eyes. The final visual acuities were improved significantly from 1.7 logMAR to 0.7 logMAR. Silicon oil was used as a tamponade in 38 eyes and SF6 gas in 25 eyes. Better functional results were achieved with SF6 gas tamponade. No intraoperative complications were reported. Most of the patients were males (71%). Statistical analysis revealed that general and ocular conditions did not influence functional results.

CONCLUSIONS. Primary PPV, especially with gas as a tamponade, is an effective procedure in the surgical treatment of pseudophakic RD. The advantages include good anatomical and functional outcomes and low complication rate. Neither clinical nor surgical factors have been identified as responsible for the visual outcomes.

Abstract

PURPOSE. To evaluate the efficacy of primary pars plana vitrectomy (PPV) for rhematogenous retinal detachment (RD) in pseudophakic eyes.

MATERIALS AND METHODS. The medical records of 63 patients who had undergone PPV after phacoemulsification were reviewed retrospectively. The mean follow-up period was 10 months. Statistical analysis evaluated functional and anatomical results as well as general (diabetes, hypertension) and ocular (myopia, glaucoma, floppy iris syndrome, intraoperative complications during cataract surgery, YAG capsulotomy) conditions.

RESULTS. The median period from cataract surgery to RD onset was 15 months. Retinal attachment was achieved in 92% of eyes. The final visual acuities were improved significantly from 1.7 logMAR to 0.7 logMAR. Silicon oil was used as a tamponade in 38 eyes and SF6 gas in 25 eyes. Better functional results were achieved with SF6 gas tamponade. No intraoperative complications were reported. Most of the patients were males (71%). Statistical analysis revealed that general and ocular conditions did not influence functional results.

CONCLUSIONS. Primary PPV, especially with gas as a tamponade, is an effective procedure in the surgical treatment of pseudophakic RD. The advantages include good anatomical and functional outcomes and low complication rate. Neither clinical nor surgical factors have been identified as responsible for the visual outcomes.

Get Citation

Keywords

retinal detachment, primary vitrectomy, pseudophakia

About this article
Title

Clinical outcomes of primary vitrectomy in pseudophakic retinal detachment

Journal

Ophthalmology Journal

Issue

Vol 1, No 1 (2016)

Pages

24-28

Published online

2016-03-30

DOI

10.5603/OJ.2016.0004

Bibliographic record

Ophthalmology J 2016;1(1):24-28.

Keywords

retinal detachment
primary vitrectomy
pseudophakia

Authors

Katarzyna Nowomiejska
Agnieszka Kalinowska
Dominika Nowakowska
Agnieszka Brzozowska
Anselm G. Jünemann
Robert Rejdak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl